Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -11.80% is 346% below its 5-year average of 4.80%, near the low end of its 5-year range (-18.01%–52.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.97% below its 12-month average of -8.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -11.80%.
RETURN ON INVESTED CAPITAL (ROIC)
-11.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-8.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-10.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
4.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-6.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-38.97%
CURRENT VS 3Y AVG
-13.02%
CURRENT VS 5Y AVG
-345.58%
CURRENT VS 10Y AVG
-90.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
+62.68%
vs the sector median at left
Fulgent Genetics, Inc.
Market Cap
$621.12M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-8.49%
3Y Avg
-10.44%
5Y Avg
4.80%
Market Cap
$620.40M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$625.03M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$638.20M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
Market Cap
$649.13M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$598.37M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$666.85M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$585.02M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$665.25M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-70.16%
3Y Avg
-61.78%
5Y Avg
-52.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | $621.12M | -11.80% | -8.49% | -10.44% | 4.80% |
| AngioDynamics, Inc. (ANGO)vs › | $620.40M | -20.75% | -20.15% | -33.64% | -24.57% |
| Climb Bio, Inc. (CLYM)vs › | $625.03M | -26.94% | -40.40% | -38.31% | -45.27% |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | -42.02% | -66.01% | -48.82% | -55.42% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $649.13M | -44.30% | -32.94% | -36.44% | -31.30% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 58.60% | 17.42% | -47.16% | -23.48% |
| MiMedx Group, Inc. (MDXG)vs › | $666.85M | 1.97% | 18.16% | 11.04% | 1.26% |
| OrthoPediatrics Corp. (KIDS)vs › | $585.02M | -4.97% | -6.49% | -6.53% | -6.86% |
| Annexon, Inc. (ANNX)vs › | $665.25M | -101.43% | -70.16% | -61.78% | -52.46% |
| Helus Pharma Inc. (HELP)vs › | $658.52M | -73.27% | -60.64% | -63.77% | -62.42% |
ROIC
-11.8%
ROE
-8.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -11.80% |
| 2026-03-31 | -9.93% |
| 2025-12-31 | -8.07% |
| 2025-09-30 | -6.21% |
| 2025-06-30 | -6.44% |
| 2025-03-31 | -6.31% |
| 2024-12-31 | -6.44% |
| 2024-09-30 | -18.01% |
| 2024-06-30 | -16.56% |
| 2024-03-31 | -16.68% |
| 2023-12-31 | -16.81% |
| 2023-09-30 | -6.23% |
| 2023-06-30 | -6.24% |
| 2023-03-31 | -3.67% |
| 2022-12-31 | 10.44% |
| 2022-09-30 | 20.24% |
| 2022-06-30 | 28.74% |
| 2022-03-31 | 33.87% |
| 2021-12-31 | 42.06% |
| 2021-09-30 | 52.75% |
| 2021-06-30 | 52.19% |
| 2021-03-31 | 51.28% |
| 2020-12-31 | 37.03% |
| 2020-09-30 | 26.02% |
| 2020-06-30 | 2.04% |
| 2020-03-31 | -0.34% |
| 2019-12-31 | -0.45% |
| 2019-09-30 | -1.92% |
| 2019-06-30 | -6.65% |
| 2019-03-31 | -9.41% |
| 2018-12-31 | -9.70% |
| 2018-09-30 | -11.62% |
| 2018-06-30 | -12.83% |
| 2018-03-31 | -11.10% |
| 2017-12-31 | -6.45% |
| 2017-09-30 | -0.20% |
| 2017-06-30 | 0.62% |
| 2017-03-31 | 3.16% |
| 2016-12-31 | 1.69% |
| 2016-09-30 | -44.57% |
| 2016-06-30 | -26.77% |
| 2016-03-31 | -96.87% |
| 2015-12-31 | -97.42% |
